Lexeo Therapeutics, Inc. Common Stock (LXEO) vs Sol-Gel Technologies Ltd. (SLGL)
A side-by-side comparison of Lexeo Therapeutics, Inc. Common Stock and Sol-Gel Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LXEO
Lexeo Therapeutics, Inc. Common Stock
$3.27HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SLGL
Sol-Gel Technologies Ltd.
$74.80HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — LXEO vs SLGL
growth of $100 · dividends reinvested · last 3yLXEO -66.1% (-30.3%/yr)SLGL +468.0% (+78.4%/yr)SLGL compounded faster over this window
Log scale — wide-divergence pair
LXEO SLGL
LXEO vs SLGL: by the numbers
- •LXEO is the larger company ($257M vs $245M market cap).
- •Both run net losses; LXEO's is the smaller (0.00% vs -910.14% net margin).
Metrics side by side
Valuation
| Metric | LXEO | SLGL |
|---|---|---|
| P/S ratio | N/A | 136.21 |
| P/B ratio | 1.09 | 5.08 |
Profitability
| Metric | LXEO | SLGL |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -38.88% |
| Net margin | 0.00% | -910.14% |
| ROE | -37.12% | -33.97% |
| ROIC | -39.76% | -35.90% |
Growth (annualized)
| Metric | LXEO | SLGL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.19% |
| Total return CAGR (5Y) | N/A | -4.19% |
Go deeper
Dig into the metrics
Lexeo Therapeutics, Inc. Common Stock ROESol-Gel Technologies ROELexeo Therapeutics, Inc. Common Stock operating marginSol-Gel Technologies operating marginLexeo Therapeutics, Inc. Common Stock revenue growthSol-Gel Technologies revenue growthLexeo Therapeutics, Inc. Common Stock free cash flowSol-Gel Technologies free cash flow
Lexeo Therapeutics, Inc. Common Stock & Sol-Gel Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.